Visningssätt för begreppens/termernas förhållanden:
Det sätt begreppsrelationer visas:
Det sätt begreppsrelationer visas:
Kliniska prövningar, fas II
Hierarki: | ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas II 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas II 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas II 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas II 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas II 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas II 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas II 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas II 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas II 5 sidobegrepp∟ ∟ ∟ ∟ ∟ |
Bredare villkor: | ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas II ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas II ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas II ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas II ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas II ∟ ∟ ∟ ∟ Kliniska prövningar, fas II ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas II ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas II ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas II |
Anmärkning: | |
Anmärkning: | Studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.
X |
Annotation: | trial lasts about 2 years; for U.S. & foreign studies; for I/II clin trials, index under CLINICAL TRIALS, PHASE I + CLINICAL TRIALS, PHASE II, for II/III clin trials, index under CLINICAL TRIALS, PHASE II + CLINICAL TRIALS, PHASE III; IM for articles & books about phase II clin trials as a method in med research; do not confuse with Publication Type CLINICAL TRIAL, PHASE II; DF: CLIN TRIALS PHASE II
X |
historyNote*: | 93; DRUG EVALUATION, FDA PHASE II was see DRUG EVALUATION 1980-92; EVALUATION STUDIES, FDA PHASE II was EVALUATION STUDIES, DRUG, FDA PHASE II see DRUG EVALUATION 1982-92
X |
onlineNote*: | use DRUG EVALUATION to search DRUG EVALUATION, FDA PHASE II 1980-92 & EVALUATION STUDIES, DRUG, FDA PHASE II 1982-92
X |
publicMeSHNote*: | 93; DRUG EVALUATION, FDA PHASE II was see DRUG EVALUATION 1980-92; EVALUATION STUDIES, FDA PHASE II was EVALUATION STUDIES, DRUG, FDA PHASE II see DRUG EVALUATION 1982-92
X |
activeMeSHYear*: | |
dateCreated*: | 1992-05-13X |
dateEstablished*: | 1993-01-01X |
dateRevised*: | 2001-07-25X |
recordAuthorizer*: | sjnX |
recordMaintainer*: | agsX |
recordOriginator*: | TPWX |
Typ: | |
Samordna villkor: | |
URI: | |
Termer och motsvarande begrepp: | Kliiniset kokeet, vaihe II (fi) XKliininen koe, vaihe II (fi, ersatt) Vaiheen II kliininen koe (fi, ersatt) Vaiheen II kliiniset kokeet (fi, ersatt) Clinical Trials, Phase II (en) Phase II Clinical Trials (en, ersatt) Phase 2 Clinical Trials (en, ersatt) Drug Evaluation, FDA Phase 2 (en, ersatt) Evaluation Studies, FDA Phase 2 (en, ersatt) Clinical Trials, Phase 2 (en, ersatt) |
Dela: |
Laddar resultat...